Ephedra Relative Risk Estimate Stands Despite Data Issues – Researchers
This article was originally published in The Tan Sheet
Even if 15% of adverse event reports are removed from consideration in the recent Annals of Internal Medicine study on ephedra safety compared with other herbals, "then relative risks we calculated remain exactly the same," the study author states in a letter published in the Sept. 2 issue of the journal
You may also be interested in...
Herbal supplements containing ephedra were associated with the majority of adverse events reported in 2001 despite representing a minute fraction of botanical sales that year, according to a recent study
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning